Practice Areas - Corporate and M&A Law Firms and Lawyers
| Deal Date: | 18-01-2016 | Practice Area: | Corporate and M&A |
| Deal Title: | Valneva SE Acquisition of Crucell Sweden AB | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Vinge advised Valneva SE in connection with its acquisition of Crucell Sweden AB, the Nordics vaccine distribution business of the seller (Crucell Holland BV) and all assets, licenses and privileges related to Dukoral, a vaccine against cholera and, in some countries, diarrhea caused by ETEC. Valneva is a Lyon based biotechnology company listed at Euronext Paris and at the Vienna stock exchange. The consideration amounted to EUR45 million and the acquisition was completed on 9 February 2015.
|
||
| Financial Center: | Stockholm | Value: | 0.00-100.00 |
| Advised Party: | Acquiror | Law Firm | Vinge |
| Target Company Jurisdiction: | Sweden | Acquiror Jurisdiction: | Sweden |
| Classification: |
Strategic Buyer Acquisitions Private Company |
Lawyer | Peter Sundgren |
